"10.1371_journal.pone.0094097","plos one","2014-04-04T00:00:00Z","Dag Tidemalm; Axel Haglund; Alina Karanti; Mikael Land√©n; Bo Runeson","Department of Clinical Neuroscience, Center for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden","Conceived and designed the experiments: BR ML DT. Performed the experiments: DT. Analyzed the data: DT AH AK ML BR. Contributed reagents/materials/analysis tools: ML DT. Wrote the paper: DT AH AK ML BR.","ML has, over the past 36 months, received compensation for lectures from AstraZeneca, Bayer, Biophausia, Bristol Myers-Squibb, Lundbeck Pharmaceuticals, Eli Lilly Sweden, Wyeth, Servier Sweden, and served at advisory board for AstraZeneca and Lundbeck pharmaceuticals. AK has, over the past 36 months, received compensation for lectures from Eli Lilly Sweden. BR has, over the past 36 months, received compensation for lectures from AstraZeneca, Lundbeck Pharmaceuticals, and Eli Lilly Sweden. The other authors have nothing to disclose. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","04","Dag Tidemalm","DT",5,TRUE,3,1,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
